Induction of cytotoxic T lymphocytes following immunization with cationized soluble antigen

Vaccine

Volumn 22, Issue 20, 2004, Pages 2609-2616

  Ikenaga, Tomoko ^a   Yamasaki, Yasuomi ^a   Shakushiro, Kohsuke ^a   Nishikawa, Makiya ^a   Takakura, Yoshinobu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cationization; CTLs; Soluble antigen

Indexed keywords

1,6 HEXANEDIAMINE; ADJUVANT; ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; CELL PROTECTION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ENDOCYTOSIS; IMMUNE RESPONSE; IMMUNIZATION; INJECTION SITE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE INJURY; TUMOR CELL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS; CATIONS; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNIZATION; MICE; MICE, INBRED C57BL; OVALBUMIN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 2942530509     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2003.12.023     Document Type: Article

References (41)

1. Germain R.N., Margulies D.H. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:1993;403
2. Harding C.V., Song R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153:1994;4925
3. Shen Z., Reznikoff G., Dranoff G., Rock K.L. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158:1997;2723
4. Norbury C.C., Chambers B.J., Prescott A.R., Ljunggren H.G., Watts C. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur. J. Immunol. 27:1997;280
5. Rodriguez A., Regnault A., Kleijmeer M., Ricciardi-Castagnoli P., Amigorena S. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell Biol. 1:1999;362
6. Regnault A., Lankar D., Lacabanne V., Rodriguez A., Thery C., Rescigno M., et al. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J. Exp. Med. 189:1999;371
7. Bansal P., Mukherjee P., Basu S.K., George A., Bal V., Rath S. MHC class I-restricted presentation of maleylated protein binding to scavenger receptors. J. Immunol. 162:1999;4430
8. Mitchell D.A., Nair S.K., Gilboa E. Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells. Eur. J. Immunol. 28:1998;1923
9. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245
10. Apple R.J., Domen P.L., Muckerheide A., Michael J.G. Cationization of protein antigens. IV. Increased antigen uptake by antigen-presenting cells. J. Immunol. 140:1988;3290
11. Farmer J.L., Roberts L.A., Rydzinski M.E., Hilty M.D. Human immune response to cationized proteins. II. Characterization of interaction of cationized diphtheria toxoid with human mononuclear cells. Cell Immunol. 146:1993;198
12. Hong G., Chappey O., Niel E., Scherrmann J.M. Enhanced cellular uptake and transport of polyclonal immunoglobulin G and fab after their cationization. J. Drug Target. 8:2000;67
13. Futami J., Maeda T., Kitazoe M., Nukui E., Tada H., Seno M., et al. Preparation of potent cytotoxic ribonucleases by cationization: enhanced cellular uptake and decreased interaction with ribonuclease inhibitor by chemical modification of carboxyl groups. Biochemistry. 40:2001;7518
14. Nishikawa M., Hasegawa S., Yamashita F., Takakura Y., Hashida M. Electrical charge on protein regulates its absorption from the rat small intestine. Am J. Physiol. Gastrointest. Liver Physiol. 282:2002;G711
15. Pfeifer J.D., Wick M.J., Roberts R.L., Findlay K., Normark S.J., Harding C.V. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature. 361:1993;359
16. Moore M.W., Carbone F.R., Bevan M.J. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell. 54:1988;777
17. Habeeb A.F. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem. 14:1966;328
18. Monsigny M., Roche A.C., Midoux P. Uptake of neoglycoproteins via membrane lectin(s) of L1210 cells evidenced by quantitative flow cytofluorometry and drug targeting. Biol. Cell. 51:1984;187
19. Nakanishi K., Watanabe Y., Maruyama M., Yamashita F., Takakura Y., Hashida M. Secretion polarity of interferon-beta in epithelial cell lines. Arch Biochem. Biophys. 402:2002;201
20. Supino R. MTT assays. Methods Mol. Biol. 43:1995;137
21. Hnatowich D.J., Layne W.W., Childs R.L. The preparation and labeling of DTPA-coupled albumin. Int. J. Appl. Radiat. Isot. 33:1982;327
22. Ke Y., Li Y., Kapp J.A. Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses. Eur. J. Immunol. 25:1995;549
23. Collins D.S., Findlay K., Harding C.V. Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses. J. Immunol. 148:1992;3336
24. Okada N., Tsujino M., Hagiwara Y., Tada A., Tamura Y., Mori K., et al. Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens. Br. J. Cancer. 84:2001;1564
25. Okada N., Saito T., Mori K., Masunaga Y., Fujii Y., Fujita J., et al. Effects of lipofectin-antigen complexes on major histocompatibility complex class I-restricted antigen presentation pathway in murine dendritic cells and on dendritic cell maturation. Biochim. Biophys. Acta. 1527:2001;97
26. Choksakulnimitr S., Masuda S., Tokuda H., Takakura Y., Hashida M. In vitro cytotoxicity of macromolecules in different cell culture systems. J. Control. Release. 34:1995;233
27. Fischer D., Li Y., Ahlemeyer B., Krieglstein J., Kissel T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials. 24:2003;1121
28. Nakanishi T., Kunisawa J., Hayashi A., Tsutsumi Y., Kubo K., Nakagawa S., et al. Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochem. Biophys. Res. Commun. 240:1997;793
29. Nakanishi T., Kunisawa J., Hayashi A., Tsutsumi Y., Kubo K., Nakagawa S., et al. Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins. J. Control. Release. 61:1999;233
30. Chikh G., Schutze-Redelmeier M.P. Liposomal delivery of CTL epitopes to dendritic cells. Biosci. Rep. 22:2002;339
31. Jameson S.C., Carbone F.R., Bevan M.J. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 177:1993;1541
32. Jameson S.C., Bevan M.J. Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb-restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Eur. J. Immunol. 22:1992;2663
33. Muckerheide A., Apple R.J., Pesce A.J., Michael J.G. Cationization of protein antigens. I. Alteration of immunogenic properties. J. Immunol. 138:1987;833
34. Muckerheide A., Domen P.L., Michael J.G. Cationization of protein antigens. II. Alteration of regulatory properties. J. Immunol. 138:1987;2800
35. Domen P.L., Muckerheide A., Michael J.G. Cationization of protein antigens. III. Abrogation of oral tolerance. J. Immunol. 139:1987;3195
36. Farmer J.L., Roberts L.A., Rydzinski M.E., Hilty M.D. Human immune response to cationized proteins. I. Characterization of the in vitro response to cationized diphtheria toxoid. Cell Immunol. 146:1993;186
37. Hahn S., Gehri R., Erb P. Mechanism and biological significance of CD4-mediated cytotoxicity. Immunol. Rev. 146:1995;57
38. Klimp A.H., de Vries E.G., Scherphof G.L., Daemen T. A potential role of macrophage activation in the treatment of cancer. Crit. Rev. Oncol. Hematol. 44:2002;143
39. Rock K.L., Clark K. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway. J. Immunol. 156:1996;3721
40. Zou J.P., Shimizu J., Ikegame K., Yamamoto N., Ono S., Fujiwara H., Hamaoka T. Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity. J. Immunol. 148:1992;648
41. Blau S., Jubeh T.T., Haupt S.M., Rubinstein A. Drug targeting by surface cationization. Crit. Rev. Ther. Drug Carrier Syst. 17:2000;425